ArticleJournal of clinical microbiology2001
Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains.
Article in Journal of clinical microbiology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 143 citations in OpenAlex.
- Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristics.BMC pediatrics · 2015Trial
- Article
- Characterisation ofFrontiers in veterinary science · 2026Article
- Current Challenges inMicroorganisms · 2025Review
- Genome Analysis of Japanese Yersinia pseudotuberculosis Strains Isolated From Kawasaki Disease Patients and Other Sources and Their Phylogenetic Positions in the Global Y. pseudotuberculosis Population.Microbiology and immunology · 2025Article
- Pathogenicity and virulence ofVirulence · 2024Review
- Pathogenic Bacteria in Free-Living Birds, and Its Public Health Significance.Animals : an open access journal from MDPI · 2024Review
- Molecular phylogenies of the plague microbeAIMS microbiology · 2023Review
- Case report: First isolation ofFrontiers in veterinary science · 2023Article
- Parallelism in Speciation and Intraspecific Diversification of the Plague MicrobeBiology bulletin of the Russian Academy of Sciences · 2023Article
- Case report: a genomics-guided reclassification of a blood culture isolate misassigned by MALDI-TOF asAccess microbiology · 2022Article
- Climate Changes in Central Asia as a Prerequisite and Trigger of Plague Microbe (Contemporary problems of ecology · 2022Article
- Analysis of Yersinia pseudotuberculosis Isolates Recovered from Deceased Mammals of a German Zoo Animal Collection.Journal of clinical microbiology · 2021Article
- Septic shock due to Yersinia pseudotuberculosis infection in an adult immunocompetent patient: a case report and literature review.BMC infectious diseases · 2021Review
- Far Eastern Scarlet-Like Fever is a Special Clinical and Epidemic Manifestation ofPathogens (Basel, Switzerland) · 2020Review
- Article
- Aetiological Significance of Infectious Stimuli in Kawasaki Disease.Frontiers in pediatrics · 2019Review
- Yersinia pseudotuberculosis Prevalence and Diversity in Wild Boars in Northeast Germany.Applied and environmental microbiology · 2018Article
- Comparative Review of Antimicrobial Resistance in Humans and Nonhuman Primates.Comparative medicine · 2018Review
- A study on the efficacy of the recombinant Yersinia adhesin A vaccine against yersiniosis in the early phase.The Journal of veterinary medical science · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Yersinia pseudotuberculosis produces novel superantigenic toxins designated YPMa (Y. pseudotuberculosis-derived mitogen), YPMb, and YPMc and has a pathogenicity island termed HPI (high-pathogenicity island) and R-HPI (the right-hand part of the HPI with truncation in its left-hand part) on the chromosome. Analysis of the distribution of these virulence factors allowed for differentiation of species Y. pseudotuberculosis into six subgroups, thus reflecting the geographical spread of two main clones: the YPMa(+) HPI(-) Far Eastern systemic pathogenic type belonging to serotypes O1b, -2a, -2b, -2c, -3, -4a, -4b, -5a, -5b, -6, -10, and UT (untypeable) and the YPMs(-) HPI(+) European gastroenteric pathogenic type belonging to serotypes O1a and -1b. The YPMa(+) HPI(+) pathogenic type belonging to serotypes O1b, -3, -5a, -5b, and UT and the YPMb(+) HPI(-) nonpathogenic type belonging to non-melibiose-fermenting serotypes O1b, -5a, -5b, -6, -7, -9, -10, -11, and -12 were prevalent in the Far East. The YPMc(+) R-HPI(+) European low-pathogenicity type belonging to non-melibiose-fermenting serotype O3 and the YPMs(-) HPI(-) pathogenic type belonging to 15 serotypes were found to be prevalent all over the world. This new information is useful for a better understanding of the evolution and spread of Y. pseudotuberculosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.